Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer
- First Posted Date
- 2013-12-30
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- Novartis Healthcare A/S
- Target Recruit Count
- 7
- Registration Number
- NCT02023359
- Locations
- 🇩🇰
Aalborg Universitetshospital, Clinical Research unit Department of oncology, Klinik Kirurgi-kræft, Hobrovej 18-22, Aalborg, Denmark
🇩🇰Department of Oncology, Odense University Hospital, Odense, Denmark
🇩🇰Onkologisk Afdelning, SVS Esbjerg, Esbjerg, Denmark
© Copyright 2025. All Rights Reserved by MedPath